Molecular Profile
What Is TB-500?
TypeEndogenous peptide/synthetic analog
CAS Number77591-33-4
Molecular Weight4,963 Da
Amino Acids43
Active RegionAc-SDKP (N-terminal)
Key Sequence17LKKTET22 (actin binding)
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Cellular Peptide
TB-500
Thymosin Beta-4Tβ4TB4Thymosin β4
A 43-amino acid synthetic fragment of thymosin beta-4 that regulates actin polymerization and promotes cell migration in preclinical research. Premium Research Peptide.
Dosage
Quantity
1
$39.99
Dosage
Quantity
1
$39.99
Thu, Apr 30 - Wed, May 6
Overnight shipping available
We accept
TB-500$39.99
Free shippingon orders over $150
Damageprotection
Secure checkout256-bit SSL
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Compound Information
Technical specifications
Expert Opin Biol Ther (2012)
Storage Requirements
Stability Information
Protect from lightStore desiccatedSterile handling
Lyophilized (powder)
-20°C•stable long-term
Reconstituted
2-8°C•use within 14-30 days
Avoid
Repeated freeze-thaw cycles
Sources & References
Peer-reviewed research
Expert Opinion on Biological Therapy
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
2012•DOI: 10.1517/14712598.2012.634793•PMID: 22074294
Goldstein AL, Hannappel E, Sosne G, Kleinman HK
View Source
Annals of the New York Academy of SciencesA randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers
2010•DOI: 10.1111/j.1749-6632.2010.05474.x•PMID: 20536472
Ruff D, Crockford D, Girardi G, Zhang Y
View Source
Journal of the Neurological SciencesA Dose Response Study of Thymosin β4 for the Treatment of Acute Stroke
2014•DOI: 10.1016/j.jns.2014.07.006•PMID: 25060418
Morris DC, Cui Y, Cheung WL, Lu M, Zhang L, Zhang ZG, Chopp M
View Source
Journal of Investigative DermatologyThymosin beta4 accelerates wound healing
1999•DOI: 10.1046/j.1523-1747.1999.00708.x•PMID: 10469335
Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK
View Source
International Journal of Molecular Sciences (PMC)Progress on the Function and Application of Thymosin β4
2021•DOI: 10.3390/ijms222413136
Xing Y, et al.
View Source
NatureThymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
2004•DOI: 10.1038/nature03000•PMID: 15565145
Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D
View Source
Clinical OphthalmologyThymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial
2015•DOI: 10.2147/OPTH.S80954•PMID: 26056426
Sosne G, Ousler GW
View Source
NeuroscienceThymosin beta4 improves functional neurological outcome in a rat model of embolic stroke
2010•DOI: 10.1016/j.neuroscience.2010.05.017•PMID: 20627173
Morris DC, Chopp M, Zhang L, Lu M, Zhang ZG
View Source
Journal of NeurosurgeryTreatment of traumatic brain injury with thymosin beta4 in rats
2010•DOI: 10.3171/2010.4.JNS10118•PMID: 20486893
Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang ZG, Morris DC, Chopp M
View Source
NatureThymosin beta4 induces adult epicardial progenitor mobilization and neovascularization
2007•DOI: 10.1038/nature05383•PMID: 17108969
Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, Riley PR
View Source
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
